NOVARTIS AG & ANR. v. CIPLA LTD. Deciding the fate of application for temporary injunction under Oder XXXIX Rules 1 and 2 of the Civil Procedure Code, in an infringement suit instituted by Novartis, the High Court of Delhi granted temporary injunction against generic drug maker Cipla Ltd restraining it from using, manufacturing, importing, selling, offering for sale, exporting, directly or indirectly dealing in Active Pharmaceutical Ingredient (API), pharmaceutical products, compound or
